Mydecine Innovations Group Inc. Announces Share for Debt Settlement
Oregon House Passes Bill to End Hard Drug Decriminalization
There are many factors in setting drug policy, which often center around the benefits or detriments to a society and its economy.
Mydecine Innovations Closes Partial Debt Settlement
Mydecine Innovations Group (0NF0.F) completed a partial settlement for its outstanding debts to an unnamed creditor, according to a Friday filing. The biotechnology company settled a $52,370.86 debt b
Psychedelic Stocks Gain After FDA Priority Review for MDMA Therapy
Mydecine Innovations Group Receives Two Notice of Allowances From USPTO for Its MYCO-005 and MYCO-006 Family of Compounds
VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NF0), a leading biotechnology co
Mydecine Innovations Group Receives Notice of Allowance From USPTO for Its MYCO-005 Compound
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a forefront biotechnology
Press Release: Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements VANCOUVER, British Columbia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group
Mydecine Innovations Group Provided Q4 2023 Business Update
Mydecine Innovations Group, Inc., (MYCO.CSE) earlier Thursday provided a general update. The company has spent the past few months simplifying its business model, streamline workflow and processes, an
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their re
Mydecine Innovations Group Starts Trading on AQSE Growth Market
Mydecine Innovations Group (MYIG.AQ) on Oct. 10 commenced trading on the access segment of the AQSE Growth Market. The biotech and life sciences company aims to develop and commercialize treatments fo
Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
Novel psychedelic-based drugs biotech Mydecine Innovations Group, Inc. (NEO:MYCO) (AQSE: MYIG) (OTC:MYCOF) (FSE: 0NFA) completed its admission to Access segment of the UK's stock market, AQSE Growth M
Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
06:17 AM EDT, 10/10/2023 (MT Newswires) -- Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting From the NEO
VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0) a biotechnology company engineering the
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering th
Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
VANCOUVER, British Columbia, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering t
Mydecine Innovations Announces Closing of Prospectus Supplement Financing
VANCOUVER, British Columbia, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering th
Mydecine Innovations Group Files Prospectus Supplement
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering th
Mydecine Innovations Group GAAP EPS of -C$0.13
Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer
Rose Hill, a Jamaica-based cultivator, supplier and exporter of premium psilocybin products and biomass to research partners and brands is now offering its first wellness retreat program under the nam
Mydecine Reports Its Special Meeting Results
VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering th
No Data